Eliminating cervical cancer in China: Opportunities come and challenges remain
Yang Cao
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Search for more papers by this authorQihao Leng
Xiangya School of Medicine, Central South University, Changsha, China
Search for more papers by this authorYan Wang
Bloomberg School of Public Health, Epidemiology, The Johns Hopkins University, Baltimore, Maryland, USA
Search for more papers by this authorCorresponding Author
Hang Yi
Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Correspondence Hang Yi and Guochao Zhang, Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Email: [email protected] and [email protected]
Search for more papers by this authorCorresponding Author
Guochao Zhang
Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Correspondence Hang Yi and Guochao Zhang, Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Email: [email protected] and [email protected]
Search for more papers by this authorYang Cao
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Search for more papers by this authorQihao Leng
Xiangya School of Medicine, Central South University, Changsha, China
Search for more papers by this authorYan Wang
Bloomberg School of Public Health, Epidemiology, The Johns Hopkins University, Baltimore, Maryland, USA
Search for more papers by this authorCorresponding Author
Hang Yi
Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Correspondence Hang Yi and Guochao Zhang, Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Email: [email protected] and [email protected]
Search for more papers by this authorCorresponding Author
Guochao Zhang
Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Correspondence Hang Yi and Guochao Zhang, Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Email: [email protected] and [email protected]
Search for more papers by this authorXu Ou-Yang and Yang Cao contributed equally to this study.
CONFLICT OF INTEREST STATEMENT
The authors declare no conflict of interest.
Open Research
DATA AVAILABILITY STATEMENT
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
REFERENCES
- 1Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health. 2020; 8(2): e191-e203. doi:10.1016/S2214-109X(19)30482-6
- 2Wang Z, Guo E, Yang B, et al. Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: cervical, ovarian and uterine cancer. Gynecol Oncol. 2021; 163(2): 358-363. doi:10.1016/j.ygyno.2021.08.029
- 3Small W, Bacon MA, Bajaj A, et al. Cervical cancer: a global health crisis. Cancer. 2017; 123(13): 2404-2412.
- 4Hammer A, Rositch A, Qeadan F, Gravitt PE, Blaakaer J. Age-specific prevalence of HPV16/18 genotypes in cervical cancer: a systematic review and meta-analysis. Int J Cancer. 2016; 138(12): 2795-2803. doi:10.1002/ijc.29959
- 5Bhattacharjee R, Das SS, Biswal SS, et al. Mechanistic role of HPV-associated early proteins in cervical cancer: molecular pathways and targeted therapeutic strategies. Crit Rev Oncol Hematol. 2022; 174:103675. doi:10.1016/j.critrevonc.2022.103675
- 6Nguyen HP, Ramírez-Fort MK, Rady PL. The biology of human papillomaviruses. Curr Probl Dermatol. 2014; 45: 19-32. doi:10.1159/000355959
- 7Schiffman M, Doorbar J, Wentzensen N, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016; 2(1):16086. doi:10.1038/nrdp.2016.86
- 8Ntuli L, Mtshali A, Mzobe G, Liebenberg LJ, Ngcapu S. Role of immunity and vaginal microbiome in clearance and persistence of human papillomavirus infection. Front Cell Infect Microbiol. 2022; 12:927131. doi:10.3389/fcimb.2022.927131
- 9Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: epidemiology, risk factors and screening. Chin J Cancer Res. 2020; 32(6): 720-728. doi:10.21147/j.issn.1000-9604.2020.06.05
- 10Harper DM, Jimbo M. Elimination of cervical cancer depends on HPV vaccination and primary HPV screening. Lancet Infect Dis. 2021; 21(10): 1342-1344. doi:10.1016/S1473-3099(20)30992-0
- 11Brisson M, Kim JJ, Canfell K, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020; 395(10224): 575-590. doi:10.1016/S0140-6736(20)30068-4
- 12Das M. WHO launches strategy to accelerate elimination of cervical cancer. Lancet Oncol. 2021; 22(1): 20-21. doi:10.1016/S1470-2045(20)30729-4
- 13Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. Morb Mortal Wkly Rep. 2019; 68(32): 698-702. doi:10.15585/mmwr.mm6832a3
- 14Colzani E, Johansen K, Johnson H, Pastore Celentano L. Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma. Euro Surveill. 2021; 26(50):2001659. doi:10.2807/1560-7917.ES.2021.26.50.2001659
- 15Linos A, Riza E. Comparisons of cervical cancer screening programmes in the European Union. Eur J Cancer. 2000; 36(17): 2260-2265. doi:10.1016/s0959-8049(00)00321
- 16 HPV vaccination: American Cancer Society | CDC. Published March 21, 2023. Accessed January 26, 2024 https://www.cdc.gov/hpv/partners/establishing-partners/acs.html
- 17 Systematic scoping review on social media monitoring methods and interventions relating to vaccine hesitancy. Published March 9, 2020. Accessed January 26, 2024 https://www.ecdc.europa.eu/en/publications-data/systematic-scoping-review-social-media-monitoring-methods-and-interventions
- 18Fuzzell LN, Perkins RB, Christy SM, Lake PW, Vadaparampil ST. Cervical cancer screening in the United States: challenges and potential solutions for underscreened groups. Prev Med. 2021; 144:106400. doi:10.1016/j.ypmed.2020.106400
- 19 Resources. Accessed January 26, 2024. https://www.europeancancer.org/resources/177:resolutions-on-hpv-cancer-elimination.html
- 20 Nation plans to launch free HPV vaccinations. Accessed January 26, 2024. https://english.www.gov.cn/statecouncil/ministries/202201/14/content_WS61e0b1c7c6d09c94e48a39ae.html
- 21 National Health Commission: focus on promoting free HPV vaccination in appropriate areas., Accessed January 26, 2024. http://health.people.com.cn/n1/2022/0712/c14739-32472847.html
- 22Li M, Zhao C, Zhao Y, Li J, Wei L. Immunogenicity, efficacy, and safety of human papillomavirus vaccine: data from China. Front Immunol. 2023; 14:1112750. doi:10.3389/fimmu.2023.1112750
- 23 Yunnan Province has achieved comprehensive county-level coverage in cervical cancer prevention and control. Accessed November 1, 2023. http://paper.cnwomen.com.cn/html/2023-06/06/nw.D110000zgfnb_20230606_1-8.htm
- 24 The plan for free HPV vaccine administration to female students in the seventh grade aged 15 and below in Jinan, Shandong Province has been confirmed. Accessed November 1, 2023. http://www.shandong.gov.cn/art/2021/10/14/art_116200_507717.html
- 25 Regarding the issuance of a notice on the accelerated cervical cancer elimination action plan (2023-2030). Accessed November 1, 2023. https://www.gov.cn/zhengce/zhengceku/2023-01/21/content_5738364.htm
- 26 Implementation plan for the accelerated cervical cancer elimination action plan in Fujian Province (2023-2030). Accessed November 1, 2023. https://wjw.fujian.gov.cn/xxgk/fgwj/zcjd/bmzcjd/202307/t20230705_6200150.htm
- 27 Implementation plan for the accelerated cervical cancer elimination action plan in Henan Province (2023-2030). Accessed November 1, 2023. https://wsjkw.henan.gov.cn/2023/08-23/2801875.html
- 28 Implementation plan for the accelerated cervical cancer elimination action plan in Hunan Province (2023-2030). Accessed November 1, 2023. http://wjw.hunan.gov.cn/wjw/xxgk/tzgg/202309/t20230906_29478571.html
- 29 Beijing initiates pilot program for HPV vaccine administration among eligible girls this year. Accessed November 1, 2023. http://health.people.com.cn/n1/2023/1008/c14739-40090833.html?from=timeline&isappinstalled=1
- 30Zhang Y, Wang Y, Liu L, et al. Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies. BMC Public Health. 2016; 16: 216. doi:10.1186/s12889-016-2873-8
- 31Wang H, Jiang Y, Wang Q, Lai Y, Holloway A. The status and challenges of HPV vaccine programme in China: an exploration of the related policy obstacles. BMJ Glob Health. 2023; 8(8):e012554. doi:10.1136/bmjgh-2023-012554
- 32Ferrall L, Lin KY, Roden RBS, Hung CF, Wu TC. Cervical cancer immunotherapy: facts and hopes. Clin Cancer Res. 2021; 27(18): 4953-4973. doi:10.1158/1078-0432.CCR-20-2833
- 33Reply to recommendation no. 5939 of the fifth session of the 13th National People's Congress. Accessed November 1, 2023. http://www.nhc.gov.cn/wjw/jiany/202211/f74d7c31d14d47fe9fec654d9619ecf3.shtml
- 34China supports the global strategy to accelerate the elimination of cervical cancer. Accessed November 1, 2023. https://www.gov.cn/xinwen/2020-12/10/content_5568770.htm
- 35National breast and cervical cancer early detection program (NBCCEDP). Accessed November 1, 2023. https://www.cdc.gov/cancer/nbccedp/about.htm
Citing Literature
